SCHEMBL120528

SCHEMBL120528

CCOC(=O)C(CS)NC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
KMT2A Q03164 2/20 0.43
POLB P06746 1/20 0.43
CAD P27708 1/20 0.42
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
CPB2 Q96IY4 1/20 0.41
ALDH1A1 P00352 3/20 0.39
ALOX15 P16050 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
NFKB1 P19838 1/20 0.38
PTGS2 P35354 1/20 0.38
THPO P40225 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL120529 1.00 L3MBTL1 (0.46) L3MBTL1KMT2APOLBCADMGAM
SCHEMBL112489 1.00 L3MBTL1 (0.46) L3MBTL1KMT2APOLBCADMGAM
Hydrochloric Acid SCHEMBL6315039 0.98 L3MBTL1 (0.44) L3MBTL1KMT2APOLBCADMGAM
Hydrochloric Acid SCHEMBL6322812 0.98 L3MBTL1 (0.44) L3MBTL1KMT2APOLBCADMGAM
Bromide SCHEMBL8314221 0.98 L3MBTL1 (0.44) L3MBTL1KMT2APOLBCADMGAM
Bromide SCHEMBL8314219 0.98 L3MBTL1 (0.44) L3MBTL1KMT2APOLBCADMGAM
SCHEMBL113196 0.83 KDM4E (0.35) L3MBTL1KMT2APOLBALDH1A1ALOX15
SCHEMBL10674538 0.83 L3MBTL1 (0.43) L3MBTL1KMT2APOLBCADMGAM
SCHEMBL8681998 0.82
SCHEMBL110065 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424499-A1 STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER Abbott Laboratories (US) 2012-03-07 EP disclosed
WO-2010127198-A1 FORMULATION FOR ORAL ADMINISTRATION OF APOPTOSIS PROMOTER ABBOTT LABORATORIES (US) 2010-11-04 WO disclosed
WO-2010127193-A1 STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER ABBOTT LABORATORIES (US) 2010-11-04 WO disclosed